Treatment with the immunotherapy dostarlimab showed promising results in a small trial of more than a dozen rectal cancer patients, according to new research, but further study is needed and it is too early to call it a cure. CNN's Erin Burnett speaks to Dr. Andrea Cercek, an oncologist at Memorial Sloan Kettering Cancer Center.
Laurie Karr
Watching this through tears and a happy heart. Lost my father to cancer last August. He was treated by a team of incredible, kind, brilliant doctors at Memorial Sloan Kettering. He benefited from various experimental treatments and trials. They helped him live 12 good years, with stage 4 metastatic colon cancer. He loved life, he loved the doctors
No comments:
Post a Comment